HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

myristamidopropyl dimethylamine

antimicrobial solution
Also Known As:
Aldox; M-dimethylamine; MADP solution
Networked: 6 relevant articles (0 outcomes, 0 trials/studies) for this Bio-Agent, Comments

Bio-Agent Context: Research Results

Experts

1. Kilvington, Simon: 2 articles (10/2003 - 06/2003)
2. Hughes, Reanne: 2 articles (10/2003 - 06/2003)
3. Sindt, Christine W: 1 article (01/2012)
4. Meadows, David L: 1 article (01/2012)
5. Kern, Jami R: 1 article (01/2012)
6. Grout, Trudy K: 1 article (01/2012)
7. Critser, D Brice: 1 article (01/2012)
8. Mowrey-McKee, Mary: 1 article (09/2007)
9. George, Melanie: 1 article (09/2007)
10. Schlech, Barry A: 1 article (03/2005)

Related Diseases

1. Cysts
09/01/2007 - "Oxysept 1 Step showed mild activity against the cysts and easyvision one step+ and OPTI-FREE Express with Aldox showed virtually no antiacanthamoeba activity against the cyst form after 6 hours of exposure."
09/01/2007 - "Mean log reductions for cysts were 1.8 for Clear Care/AOSEPT Plus, 2.0 for BLUE Vision/BLUE SEPT, 0.7 for Oxysept 1 Step, 0.5 for OPTI-FREE Express with Aldox, and 0.2 for easyvision one step+. Mean log reductions for trophozoites were 2.2 for Clear Care/AOSEPT Plus, 2.7 for BLUE Vision/BLUE SEPT, 2.5 for Oxysept 1 Step, 2.5 for OPTI-FREE Express with Aldox, and 1.8 for easyvision one step+. Only Clear Care/AOSEPT Plus and BLUE Vision/BLUE SEPT showed high levels of antimicrobial activity against the cyst form of A. "
03/01/2005 - "The multipurpose solution containing polyquaternium-1 and myristamidopropyl dimethylamine reduced more cysts and trophozoites than did the alternative solution tested. "
01/01/1998 - "The amoebicidal activity of a contact lens multipurpose disinfecting solution (MPDS) containing polyquaternium-1 and myristamidopropyl dimethylamine was compared to a disinfection/neutralisation peroxide system against Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites and cysts. "
10/01/2003 - "The effects of age in culture and the type of medium used for induction of Acanthamoeba polyphaga (Ros) cysts on susceptibilities to polyhexamethylene biguanide (PHMB; 3 micro g/ml), chlorhexidine digluconate (30 micro g/ml), myristamidopropyl dimethylamine (20 micro g/ml), H(2)O(2) (3%), and two multipurpose contact lens solutions (MPS-1 and MPS-2, based on 1 micro g of PHMB per ml) were examined. "
Order ALL the reference details at left...
2. Keratitis
3. Blister (Bulla)

Related Drugs and Biologics

1. polyquaternium 1 (polyquaternium-1)
2. polyhexamethylene biguanide
3. Contact Lens Solutions (Contact Lens Solution)
4. chlorhexidine gluconate (Dyna-Hex)

Related Therapies and Procedures

1. Lenses

blog comments powered by Disqus
TREATMENT OPTIONS
for Cysts,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 544 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>